International Journal of Obstetric Anesthesia
Volume 18, Issue 2 , Pages 156-164 , April 2009

Pulmonary hypertension and pregnancy

  • B.P. Madden

      Affiliations

    • Corresponding Author InformationB. P. Madden, Professor of Cardiothoracic Medicine, St George’s Hospital, Blackshaw Road, Tooting London SW16 0QT, UK. Tel.: +0208 725 1094.

,Accepted 5 October 2008.

References 

  1. Wagenvoort CA, Wagenvoort H. Primary pulmonary hypertension: a path pathologic study of the lung vessels in 156 classically diagnosed cases. Circulation. 1970;42:1163–1184
  2. Madden B, Gosney J, Coghlan J, et al. Pre-transplant clinicopathological correlation in end-stage primary pulmonary hypertension. Eur Respir J. 1994;7:672–678
  3. Thompson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BPMR-11, a receptor member of the TGF-β family. J Med Genet. 2000;37:741–745
  4. D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115:343–349
  5. Rubin L J; American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest 2004; 126: S1–S92.
  6. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161:487–492
  7. Ueland K. Maternal cardiovascular dynamics. VII. Intrapartum blood volume changes. Am J Obstet Gynecol. 1976;126:671–677
  8. Pritchard J. Changes in the blood volume during pregnancy and delivery. Anesthesiology. 1965;26:393–399
  9. Lund C, Donovan J. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol. 1967;98:394–403
  10. Foley M. Maternal cardiovascular adaptation to pregnancy. In: Rose B, ed. UpToDate, vol 13.2, Wellesley: MA; 2005.
  11. Robson S, Hunter S, Boys R, Dunlop W, Bryson M. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060–H1065
  12. Capeless E, Clapp J. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol. 1989;161:1449–1453
  13. Duvekot J, Peeters L. Maternal cardiovascular hemodynamic adaptations to pregnancy. Obstet Gynecol Surv. 1994;49:S1–S14
  14. McCaffrey R, Dunn L. Primary pulmonary hypertension in pregnancy. Obstet Gynecol Surv. 1964;19:567–591
  15. Clapp JF, Capeless E. Cardiovascular function before, during and after the first and subsequent pregnancies. Am J Cardiol. 1997;80:1469–1473
  16. Pechet L, Alexander B. Clotting factors in pregnancy. N Engl J Med. 1961;265:1093–1097
  17. Walker M, Garner P, Keely E, et al. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol. 1997;177:162–169
  18. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal conditions. Gynecol Obstet Invest. 1981;2:141–154
  19. Weiss B, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systemic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650–1657
  20. Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845–1855
  21. Jaigobin C, Silver F. Stroke and pregnancy. Stroke. 2000;31:2948–2951
  22. McPhedran P. Venous thromboembolism during pregnancy. In: Burrow G, Duffy T, Copel J, eds. Medical complications during pregnancy. Philadelphia: Elsevier Saunders; 2004: 87–102.
  23. Gleicher N, Midwall J, Hochberger D. Eisennmenger’s syndrome and pregnancy. Obstet Gynecol. 1979;34:721–741
  24. Weiss B, Hess O. Pulmonary vascular disease and pregnancy: Current controversies, management strategies and perspectives. Eur Heart J. 2000;21:104–115
  25. Satoh H, Masuda Y, Izuta S, Yaku H, Obara H. Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy. Anesthesiology. 2002;97:1638–1640
  26. Clouthier D, Williams S, Hammer R, Richardson JA, Yanagisawa M. Cell-autonomous and nonautonomous actions of endothelin-A receptor signalling in craniofacial and cardiovascular development. Dev Biol. 2003;261:506–519
  27. Warnes C. Pregnancy and pulmonary hypertension. Int J Cardiol. 2004;97:11–13
  28. Al-Mobeireek A, Almutawa J, Alsatli R. The nineteenth pregnancy in a patient with cor pulmonale and severe pulmonary hypertension: a management challenge. Acta Obstet Gynecol Scand. 2003;82:676–678
  29. ACOG (Committee Opinion). Safety of Lovenox in pregnancy. Obstet Gynecol 2002; 100: 845–6.
  30. Bates S, Greer I, Hirsh J, Ginsberg JS. Use of antithrombotic agents in pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):627S–644S
  31. MacLean MR. Endothelin-1: a mediator of pulmonary hypertension?. Pulm Pharmacol Ther. 1998;11:125–132
  32. Benigni A, Remuzzi G. Endothelin antagonists. Lancet. 1999;353:133–138
  33. Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo controlled study. Lancet. 2001;358:1119–1123
  34. Barst RJ, Langleben D, Frost A, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;169:441–447
  35. Madden BP, Allenby M, Loke TK, Sheth A. A potential role for sildenafil in the management of pulmonary hypertension associated with parenchymal lung disease. Vasc Pharmacol. 2006;44:372–376
  36. Madden BP, Sheth A, Ho T, Kanagasabay R. A potential role for sildenafil in the management of perioperative pulmonary hypertension and right ventricular dysfunction following cardiac surgery. Br J Anaesth. 2004;93:155–156
  37. Sheth A, Park JS, Ong YE, Ho T, Madden BP. Early haemodynamic benefit of sildenafil in patients with co-existing chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vasc Pharmacol. 2005;42:41–45
  38. Madden BP, Sheth A, Wilde M, Ong YE. Does sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?. Vasc Pharmacol. 2007;47:184–188
  39. La Cassie H, Germain A, Valdes G, Fernández MS, Allamand F, López H. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol. 2004;103:1118–1120
  40. Easterling T, Ralph D, Schmucker B. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93:494–498
  41. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy. Chest. 2001;119:973–975
  42. Lam GK, Stafford RE, Thorp J, Moise KJ, Cairns BA. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol. 2001;98:895–898
  43. Decoene C, Bourzoufi K, Moreau D, Narducci F, Crepin F, Krivosic-Horber R. Use of inhaled nitric oxide for emergency Cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth. 2001;48:584–587
  44. McDonnell NJ, Chan BO, Frengley RW. Rapid reversal of critical haemodynamic compromise with nitric oxide in a parturient with amniotic fluid embolism. Int J Obstet Anesth. 2007;16:269–273
  45. Nihill MR, O’Laughlin MR, Mullins CE. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diagn. 1991;24:166–172
  46. Smedstad KG, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: A series of eight cases. Can J Anaesth. 1994;41:502–512
  47. Vongpatanasin W, Brickner M, Hillis L, Lange RA. The Eisenmenger syndrome in adults. Am Intern Med. 1998;128:745–755
  48. Mushlin P, Davidson K. Cardiovascular disease during pregnancy. In: Datta S, ed. Anesthetic and obstetric management of high-risk pregnancy. New York: Springer; 1996.

PII: S0959-289X(08)00188-X

doi: 10.1016/j.ijoa.2008.10.006

International Journal of Obstetric Anesthesia
Volume 18, Issue 2 , Pages 156-164 , April 2009